![]() Germany International Organization No tags have been applied so far. Ernesto himself served as navigator in 2003 and as an afterguard runner and grinder in 2007, when Alinghi defended the America’s Cup in Valencia, Spain. Lynkeus Biotech GmbHs PlainSite profile, including litigation, intellectual property, public records and more. The victory brought the Cup back to Europe for the first time since 1851. In 2000, Ernesto founded the yachting team Alinghi, which in 2003 defeated Team New Zealand in Auckland to win the America’s Cup, the first time a team had ever won the coveted sailing trophy on its first attempt. He was also awarded the Légion d’Honneur by President Jacques Chirac of France and the Cavaliere di Gran Croce by Carlo Azeglio Ciampi, President of the Italian Republic. In 2008 he was inducted into Babson College’s Academy of Distinguished Entrepreneurs. He is also the Vice Chair of the Harvard Medical School Board of Fellows, a member of the Strategic Advisory Board at Ecole Polytechnique Fédérale de Lausanne (EPFL), and he is a member of the Stanford Medicine Board of Fellows. Between 20 he served as a board director of UBS AG.Įrnesto is the Co-Chair of the Bertarelli Foundation. In 2007, Serono was sold to Merck KGaA of Germany.Įrnesto’s current business interests include B-FLEXION (formerly Waypoint Capital), a private entrepreneurial investment firm that oversees growth-oriented operating businesses and asset managers. Under his leadership, Serono shifted its focus from pharmaceuticals to biotechnology and, over the course of the ensuing decade, revenues more than tripled. ![]() Further instrAction develops purification processes based on these proprietary phases. Yet more scientific and technological breakthroughs are on the horizon. The instrAction GmbH is a young, dynamic, and growing company which develops and produces modern chromatographic phases based on an innovative, patent protected technology (instrAction technology). Pharmaceutical and veterinary preparations, in particular for treating ocular conditions, metabolic disorders and tumours preparations for health care dietetic substances adapted for medical use.Ernesto was appointed CEO of Serono in 1996. Biotech is entering its next S-curve of growth as companies work to transform an array of innovationsgene therapies, stem-cell treatments, antisense DNA, siRNA, 1 CAR-T 2 into powerful new therapeutic tools. Scientific and industrial research chemistry, biochemistry and biology services, in particular contract research and diagnostics chemistry and biochemistry services drawing up gene therapy protocols computer programming. The project aims to define, then test, a preliminary concept. LynkEUs is a project selected by the European Commission on July 2020 as part of the European Defence Industrial Development Programme 2019. Trademark is used in the following business:Ĭhemicals, in particular biochemical and molecular biological products used in industry and science.Ĭonsultancy, arranging and conducting of seminars, lectures and information events in the fields of molecular biology, genetic engineering, molecular diagnostics, gene therapy and molecular medicine. The LynkEUs project attests of the ability of MBDA to implement complex projects and bring together skills and expertise from across Europe. The current status of the LYNKEUS Bio Tech filing isīased on LYNKEUS BioTech GmbH, the LYNKEUS Bio Tech Patentanwälte Isenbruck Bösl Hörschler PartG mbB ![]() PATENTANWÄLTE ISENBRUCK BÖSL HÖRSCHLER PARTG MBB, The legal correspondent for LYNKEUS Bio Tech trademark is The LYNKEUS Bio Tech mark is filed in the category ofĬomputer & Software Services & Scientific Services Trademark Application Number is a unique ID to identify the LYNKEUS Bio Tech mark in EUIPO. The LYNKEUS Bio Tech trademark was assigned an Application Number # 002702918 – by the European Union Intellectual Property Office (EUIPO). ![]() Wacker Biotech is now a leader in this sector. ![]() LYNKEUS Bio Tech European Union Trademark Information By LYNKEUS BioTech GmbH Simonime pentru Lynkeus i traducerea Lynkeus în 25 de limbi. In the course of its multiple activities, Lynkeus has been interacting with over 100 partners and customers, ranging from: academia (Coventry University, Delft University of Technology, Erasmus Universitair Medisch Centrum Rotterdam, HES-SO, Johns Hopkins University, Katholieke Universiteit Leuven, London School of Economics, McGill University. With Wacker Biotech GmbH, WACKER FINE CHEMICALS (today’s WACKER BIOSOLUTIONS) took a decisive step toward transforming its existing pharmaceutical contract-manufacturing business into the contract-development and manufacturing of therapeutic proteins. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |